161 results about "Saline solutions" patented technology

The invention disclosed in this document presents a novel direct in-scope suction system designed for the retrieval of calculus fragments within the body. This system comprises two key components: a calculus fragments retrieval device and a pump unit. The calculus fragments retrieval device features a body with a single working channel that includes both an irrigation port and a suction port, which are connected to respective irrigation and suction pumps via elastomer-based rubber tubes. This setup allows for the controlled infusion of saline solution into the body lumens during lithotripsy procedures, ensuring clear visibility and fragment clearance. The retrieval device includes a trigger lever connected to a pincher tab. When the operator presses the trigger lever, the suction port is opened by releasing the pinched suction tube, increasing pressure inside the body.

The invention belongs to the field of medical isotope separation and preparation, and particularly relates to a method for separating and purifying < 212 > Pb from a thorium solution, which comprises the following steps: 1) leacheate is introduced into a Pb selective adsorption column to pretreat the Pb selective adsorption column, and then < 232 > Th salt solution and leacheate are introduced in sequence; 2) continuously introducing a desorption solution into the Pb selective adsorption column, enabling the desorption solution passing through the Pb selective adsorption column to flow into the Th selective adsorption column, and collecting the outflowing desorption solution; a desorption solution only containing 212Pb is obtained; according to the method, the 212Pb in the high-concentration thorium solution can be separated and purified at the same time. While < 232 > Th impurity entrainment and pollution in a < 212 > Pb product are remarkably reduced, compared with a single-column process, the separation time is basically not increased. The separated 212Pb product has high radionuclide purity and chemical purity at the same time, and can meet related pharmaceutical requirements.

The invention provides an oral thylakoid product for resisting organ failure and aging, which is prepared by the following steps: extracting thylakoid from plants including spinach, arabidopsis thaliana, lettuce, cabbage, green algae or wheat seedlings, redissolving the thylakoid into a buffer salt solution A, and carrying out ultrasonic treatment for 10-20 minutes under the ultrasonic power of 200-500W to prepare a suspension; adjusting the concentration of the suspension to 0.5-2 mg / ml, and obtaining a nano capsule-like body with the particle size of 200-500 nm by using a microfluidic technology; the buffer salt solution A is prepared from 10 to 100 mmol / L of 4-hydroxyethyl piperazine ethanesulfonic acid (HEPES), 1 to 2 mmol / L of ethylenediamine tetraacetic acid (EDTA) disodium, 0.5 to 4 mmol / L of magnesium chloride (MgCl2), 1 to 10 mmol / L of ascorbic acid and 100 to 500 mmol / L of sapoeda sodium (SNAC), and the pH value of the buffer salt solution A is adjusted to 7.5 to 8.0; and the concentration of the capsule in the buffer salt solution A is 100-400 mg / mL. According to the product, self QPRT enzyme of the thylakoid is used for efficiently catalyzing de novo synthesis of NAD + of whole body tissues and organs, so that multiple physiological processes such as energy synthesis enhancement, oxidative stress reduction and inflammatory reaction relief are finally realized, organ failure is efficiently reversed, and organ aging is relieved.

The present invention relates to a method for synthesizing nanoparticles comprising or containing at least one zeolite nanocrystal, comprising: - preparing a first composition / solution 1 comprising an aluminum source and a source of alkali metal M, particularly Na ions; - preparing a second composition / solution 2 comprising a silicon source and a source of alkali metal M, particularly Na ions, wherein compositions / solutions 1 and 2 contain no organic structuring agents; - mixing the two compositions / solutions 1 and 2; - crystallizing the mixture; and - separating the nanoparticles thus formed. According to the present invention, both the first composition / solution 1 and the second composition / solution 2 comprise the sources and alkaline phosphate buffer (PBS). The present invention also relates to the obtained nanoparticles and compositions comprising them.

This invention belongs to the field of biochemical detection and discloses a portable hepatitis biomarker detection kit. The kit contains a hydrogel; the hydrogel is obtained by dispersing hollow manganese dioxide in water to obtain an H-MnO2 dispersion, mixing the H-MnO2 dispersion with sodium alginate solution to obtain a mixed solution, and then adding a calcium salt solution to obtain the hydrogel. The hollow manganese dioxide is obtained by etching manganese Prussian blue analog nanoparticles with sodium hydroxide. The manganese Prussian blue analog nanoparticles are prepared from potassium ferricyanide, polyvinylpyrrolidone, and manganese salts. This invention utilizes the color change of hollow manganese dioxide in relation to TMB to construct a method for detecting hepatitis biomarkers using a smartphone to capture signals. This kit reduces the detection cost of hepatitis biomarkers, does not require large instruments, and is highly portable and widely applicable, possessing great potential as a novel point-of-care testing device.

This invention provides a transcervical access system for moving fluids transcervically. [Solution] The transcervical access system 100 is effective in transferring a wide range of fluids into the uterine cavity, including the delivery of a hydrogel precursor, saline solution, and imaging fluid. The transcervical access system 100 is also effective in removing fluids, such as residual bodily fluids, residual fluids from procedures, or tissue from the uterine cavity. The transcervical access system 100 includes a flow limiter, such as an outflow limiter 106 and / or a cervical plug. A method of using the transcervical access system 100 involves using the transcervical access system 100 to transcervically access the uterine cavity and to install the hydrogel. The transcervical access system 100 and related methods are useful in preventing adhesions after intrauterine procedures by providing a biodegradable hydrogel within the uterine cavity, including the cervix.

The present invention relates to aqueous saline solutions comprising dantrolene and optionally at least one additional active ingredient, such as botulinum neurotoxin, and their use for various therapeutic and / or aesthetic purposes. The solutions can be administered in any suitable manner, but have the advantage of being particularly well-suited for intramuscular injection.

The utility model relates to the technical field of chemotherapeutic drug preparation, and discloses a closed chemotherapeutic drug preparation device, which comprises an installation cylinder, a powder bag and a liquid bottle are arranged in the installation cylinder, the powder bag and the liquid bottle are arranged up and down, a configuration structure is arranged in the installation cylinder, and the configuration structure comprises two partition plates fixed in the installation cylinder. Through the arrangement of the configuration structure, a worker puts a powder bag into the mounting cylinder, slides the powder bag into the corresponding partition plate to be clamped, inserts a first needle head into a connector of the powder bag, slides a second needle head into the partition plate above to be clamped, puts a liquid bottle into the mounting cylinder, penetrates the second needle head into the liquid bottle, and flows liquid into the powder bag through the needle heads and a conveying pipe; preliminarily mixing with the medicinal powder; then a motor is started to drive a cam to rotate and push a movable plate to lift in a reciprocating manner, vibration is applied to the powder bag under the action of a spring, dissolution and mixing of medicine powder and saline water are accelerated, rapid and uniform preparation is achieved, and the chemotherapeutic medicine preparation efficiency and effect are improved.

The invention relates to a preparation method of a plastic bone grafting material and the plastic bone grafting material.The preparation method comprises the following steps that a, phenyl phosphate lithium salt is dissolved in a phosphoric acid buffer salt solution to obtain a mixed solution, and Ge MA is dissolved in the mixed solution to obtain a Ge MA gel solution; b, bone meal and the Ge MA gel solution are subjected to a cross-linking effect, so that the bone meal and the Ge MA gel solution are fully mixed, then light source irradiation is conducted, the bone meal hydrogel bone grafting material is obtained, and the particle size of the bone meal is 0.25-0.5 mm. According to the preparation method of the plastic bone grafting material, provided by the invention, the bone meal and the Ge MA gel solution are subjected to cross-linking and then subjected to light source irradiation, so that the bone meal and the hydrogel are uniformly mixed, the compatibility of an organic phase and a bone meal particle interface is good, and the prepared plastic bone grafting material is relatively high in plasticity and good in osteoinductivity; and the cell adhesion rate is high.

The invention discloses a water-based drilling fluid system resistant to a high-concentration mixed saline solution and a preparation method of the water-based drilling fluid system, and belongs to the technical field of drilling fluids. According to the water-based drilling fluid system resistant to the high-concentration mixed saline solution, the influence of cations with different valence states and an underground high-temperature and high-pressure environment on the rheological property, the filtration performance and the like of the drilling fluid is fully considered, and two high-valence cation-resistant drilling fluid filtrate reducers are introduced; the technical problems that a conventional drilling fluid is poor in rheological property, poor in filtrate loss reduction performance, poor in system stability and the like in high-concentration mixed salt water are solved. The system can meet the requirement for rapid drilling of a stratum at the ground temperature of 150 DEG C and the high salt ion concentration, can still keep good capacities of carrying rock, lubricating, blocking and preventing collapse, inhibiting clay hydration and dispersion and the like in a high-concentration mixed salt water solution, does not need precise instruments and equipment, is simple and easy to operate, low in cost and good in economical efficiency, can be prepared and used at any time, and has wide application prospects. The method is suitable for drilling conditions.

The invention provides a process for preparing a plasticised superporous hydrogel material comprising subjecting initial hydrogel material to treatment with an acidic solution, an optional treatment with a monovalent metal salt solution, freeze drying and plasticisation. Optionally, the process of the invention produces moulded plasticised superporous hydrogel material bodies that have one or more through-holes formed therein. The plasticised superporous hydrogel material of the present invention may be formulated as a suitable oral dosage form for use an appetite suppressant and for use to deliver a pharmaceutical and / or nutraceutical into a human or animal body.

The application discloses a method for generating nitric oxide gas, and belongs to the field of gas preparation and medical treatment, and is characterized in that the method for generating nitric oxide gas is to mix liquid medicament with solid medicament, to make the liquid medicament and the solid medicament react chemically, so as to generate nitric oxide gas with a certain concentration, the effective component of the solid medicament is nitrosyl iron sulfate, and the liquid medicament is one or a mixture of several kinds of alkali solution or slurry and salt solution or slurry. The application further discloses a corresponding device for generating nitric oxide gas.

This invention provides an infusion device for PICCO-compatible saline solution, comprising a syringe, a sealing assembly, and a transmission mechanism. The syringe head has an inlet tube and an outlet tube communicating internally. The syringe head also has a groove connecting the inlet and outlet tubes. The sealing assembly is slidably connected within the groove and can seal either the inlet or outlet tube. The transmission assembly is rotatably mounted on the syringe head and connected to the syringe plunger. Pulling the plunger outward causes the sealing assembly to slide intermittently via the transmission assembly, moving it from sealing the outlet tube to sealing the inlet tube when pushed to its maximum distance; pushing inward reverses this process. This infusion device for PICCO-compatible saline solution allows for changing the sealing status of the inlet and outlet tubes through outward and inward pulling, respectively, eliminating the need to repeatedly move the syringe interface. The inlet tube is connected to a cold water bag, and the outlet tube is connected to a three-way connector.

The present invention relates to a method for synthesizing nanoparticles comprising or containing at least one zeolite nanocrystal, comprising: - preparing a first composition / solution 1 comprising an aluminum source and a source of alkali metal M, particularly K ions; - preparing a second composition / solution 2 comprising a silicon source and a source of alkali metal M, particularly K ions, wherein compositions / solutions 1 and 2 contain no organic structuring agents; - mixing the two compositions / solutions 1 and 2 together; - crystallizing the mixture; and - separating the nanoparticles thus formed. According to the present invention, both the first composition / solution 1 and the second composition / solution 2 consist of the sources and phosphate-buffered saline. The present invention also relates to a colloidal suspension of the obtained nanoparticles and a pharmaceutical composition containing the nanoparticles.

The present application relates to the technical field of wound dressing, and particularly relates to a chitosan modified clay-based aerogel wound dressing and a preparation method thereof. The preparation method comprises the following steps: S1: adding clay minerals into deionized water to prepare a slurry, and adding acetic acid while stirring to obtain a clay mineral slurry; S2: dissolving chitosan in an acetic acid solution to prepare a chitosan sol; S3: continuously stirring and mixing the clay mineral slurry and the chitosan sol to obtain a sol; S4: immersing the sol in a metal cation solution first, and then immersing the sol in an anion salt solution to obtain a standing product; and S5: freeze-drying the standing product to obtain a composite aerogel. The present application successfully constructs a three-dimensional porous aerogel dressing, which not only retains the strong hemostatic ability of clay, but also significantly enhances the mechanical strength and antibacterial performance, and exhibits great potential in the treatment of high-exudation complex wounds such as diabetic foot ulcers and infected wounds.

The utility model discloses a brine blending device for a red blood cell osmotic brittleness test. The brine blending device comprises a main shell and a position mark sensing unit, a salt water blending unit and a center alignment unit; a master controller; a to-be-loaded test tube group is placed on the bottom placing table, the center alignment unit is used for placing the to-be-loaded test tube group in the middle position, the position mark sensing unit is used for measuring and calculating the distance between the head test tube and the tail test tube of the test tube group so as to guide the horizontal moving unit to rapidly move to the position over the test tubes relative to the center of the device, and the visual camera and the injection angle adjusting assembly are used for adjusting the injection angle. The injection head is aligned with a test tube opening, and the metering pump is started to inject saline water and distilled water into the test tube according to a fixed proportion. Based on a saline water filling mode of mobile hovering injection, a horizontal moving unit is arranged to realize movement of an injection head above a test tube group, so that the problem of material resource waste caused by a traditional one-tube one-path scheme is solved; in addition, by arranging a visual camera and an ejection angle adjusting assembly, the technical risk that saline water is injected out of the test tube is avoided to a great extent.

The present invention relates to a single-phase, spherical edible microcarrier for the three-dimensional culture of stem cells intended for the preparation of cultured meat. The microcarrier comprises a homogeneous mixture of edible ionic polysaccharide (0.375-1.5%), edible protein (1-2.5%), edible polymer (0.025-0.1%) and water (95.9-98.6%). The invention also relates to a method for preparing these microcarriers by mixing three solutions: ionic polysaccharide in saline solution, edible protein in saline solution and edible polymer in water. The mixture is subjected to a process involving microspraying or electrospraying with calcium chloride in order to form spherical microcarriers of 50-300 micrometres. The design of the single-phase, spherical edible microcarrier simplifies the production of cultured meat by dispensing with the need for core-shell structures, thereby improving cell anchorage efficiency and facilitating cell recovery.

A ready-to-use, gamma-ray sterilized, surgical antiseptic composition comprising an initial non-toxic concentration of povidone-iodine above a minimum effective concentration of available iodine, iodide in sufficient quantity to provide donor iodine upon gamma irradiation to stabilize said povidone-iodine and maintain said minimum effective concentration of available iodine, and a buffered saline solution.

The invention relates to the technical field of medical analysis, in particular to a method for detecting the content of an antioxidant in bromfenac sodium eye drops through liquid chromatography, and particularly relates to a method for detecting the content of the antioxidant anhydrous sodium sulfite of the bromfenac sodium eye drops through high performance liquid chromatography. Wherein the mobile phase A is a methanol-buffer salt solution; a mobile phase B is methanol; eluting by using a gradient mobile phase, wherein the volume ratio of the mobile phase is 100%; preparing a reference solution and a test solution by taking the mobile phase A as a diluent, then respectively injecting the reference solution and the test solution into a liquid chromatograph, and recording chromatograms; calculating the content of anhydrous sodium sulfite by adopting an external standard method; the method comprises the following specific steps: (1) preparation of a reference substance solution: taking an anhydrous sodium sulfite reference substance, and adding a diluent for dissolving to obtain the reference substance solution; and (2) preparation of a test solution: taking the bromfenac sodium eye drops, and adding a diluent to dilute the bromfenac sodium eye drops to obtain the bromfenac sodium eye drops. The method disclosed by the invention is strong in specificity, high in stability, high in precision and high in accuracy, and has practical significance on quality control of the bromfenac sodium eye drops.

The present invention relates to an ophthalmic ultrasonic emulsification sleeve for confirming intraocular and extraocular penetration and perfusion, which allows determining whether aqueous humor communication between the inside and outside of the eye is smooth through a microtube implanted in the eye during glaucoma tube surgery. The sleeve is characterized by having a rigid branch tube made of a material harder than a sleeve made of a soft material, provided in a perfusion port that allows the injection of a balance salt solution into the eye, and with the branch tube connected to the perfusion port, the tip of the branch tube protrudes further than the tip of the Paco tip, and the end of the microtube inside the eye is connected to the tip of the branch tube, so that the establishment of aqueous humor communication of the microtube can be quickly and accurately and sensorially confirmed based on the pattern of pressure change in the conjunctival area and surrounding blood flow change that occurs when the balance salt solution leaks out of the eye.

The application relates to the technical field of drug delivery, in particular to a microemulsion delivery system and a preparation method and application thereof. The microemulsion delivery system comprises a dispersed phase, an interface film wrapping the dispersed phase and a continuous phase; a complex formed by the continuous phase and the interface film is dispersed in the continuous phase; the dispersed phase comprises rosemary oil and quercetin; and the continuous phase comprises adenosine and a buffer salt solution. The microemulsion delivery system has high drug loading, good transdermal performance and obvious therapeutic effect on androgenetic alopecia.

FIELD: otorhinolaryngology.SUBSTANCE: under endotracheal anesthesia, an endoscope equipped with optics and an instrument for removing pathological contents of the maxillary sinus are inserted into the nasal passage. The inferior nasal concha is displaced medially using a raspatory. Then, stepping back from the edge of the piriform opening by 1.5–2.0 cm in the caudal direction, a mucoperiosteal flap of the lateral wall is separated in the lower nasal passage. The mucoperiosteal flap is displaced posteriorly, exposing the bone skeleton in the projection of the inferomedial angle of the maxillary sinus. Next, using a cold plasma coblator, in ablation mode, the mucous surface of the bone skeleton is evaporated for 2–3 seconds, followed by coagulation of small vessels. Then, a bone valve measuring 10–15 mm is formed from the exposed bone skeleton. The bony valve is retracted in the caudal direction, forming an antrostomy. A 70-degree endoscope is inserted through the formed antrostomy and the pathological contents of the sinus are visualized. In this case, if the cyst is visualized with a coblator in ablation mode, the cyst is evaporated along with its contents, and the remaining cyst is captured and removed. If a polyp is visualized, the polyp stalk is first evaporated, and then the remaining part of the polyp is removed. If a foreign body is visualized, it is removed with forceps. In this case, if the foreign body is encapsulated or located in the thickness of the mucosa, a coblator in ablation mode evaporates part of the mucosa until the foreign body is exposed, and then removed. Next, the sinus cavity is washed with saline solution. The antrostomy is closed with a bone flap. The formed mucoperiosteal flap is placed back in its original place.EFFECT: method allows for endoscopic endonasal removal of pathological contents from the maxillary sinuses with a minimal risk of cyst / polyp recurrence and postoperative complications, reduced blood loss during surgery, shortened surgical time, postoperative rehabilitation periods, and temporary disability.3 cl, 3 ex

The invention relates to a process for producing microparticles loaded with at least one flavonoid and / or flavonoid derivative, comprising the following successive steps: a) Mixing a water component in the form of an aqueous solution comprising the at least one flavonoid and / or flavonoid derivative with an oil component to form a solution of polylactide-co-glycolide in an organic solvent, to form a water-oil emulsion; b) Mixing the water-oil emulsion from step a) with another water component in the form of an aqueous solution comprising at least one stabilizer, to form a water-oil-water emulsion, c) Mixing the water-oil-water emulsion with an aqueous salt solution; d) Removal of the organic solvent in the water-oil-water emulsion to form a suspension comprising the microparticles loaded with at least the flavonoid and / or flavonoid derivative; e) Separating the loaded microparticles from the liquid of the suspension. Furthermore, the invention relates to microparticles, the use of which for the manufacture of a medicinal product, a dispersion containing the microparticles for use in the treatment and / or prophylaxis of oral infections, as well as non-medical use in cosmetics.

Disclosed is a method for preparing Au-Ru nanoenzymes, with steps as: 1) dissolving HAuCl4 and ruthenium metal salt in solvent to obtain metal salt solution; 2) adding NAC and TA to the metal salt solution, mixing them uniformly to obtain mixture; 3) adding NaBH4 aqueous solution to the mixture, stirring to react at room temperature, then continuing to stir to react at 50° C.˜70° C.; after the reaction is finished, performing centrifuging, and the precipitate is lyophilized to obtain Au—Ru nanoenzymes. The present invention further discloses a method for preparing ATBMzyme nanoenzymes, specifically: adding EDC and NHS to Au—Ru nanoenzymes solution, stirring to react, then adding brain natriuretic peptide to the reaction system, continuing to stir to react; after the reaction is finished, performing centrifuging, and the precipitate is lyophilized to obtain ATBMzyme nanoenzymes.

To provide a structure for manufacturing a container in which different components are attached together with an adhesive, thereby improving the efficiency of observing biologically derived substances. [Solution] The structure comprises a base material having a plurality of through holes opening in the vertical direction, and an adhesive layer provided on the lower surface of the base material, to which a sheet that closes the through holes is attached. The adhesive layer is formed by attaching a test piece cut to a size of 10 mm × 10 mm, with an opening diameter of 16.2 mm, a well depth of 18 mm, and a well volume of 3.5 mL, to the bottom surface of a tissue culture polystyrene well having an opening below the through holes, with an outer shape in plan view larger than the outer shape of the through holes, and filling the well with 0.5 mL of a phosphate-buffered saline solution with a concentration of 5 μM rhodamine B, and letting it stand at 23°C for 48 hours, and the adhesive is formed by an adhesive such that the remaining percentage of rhodamine B in the solution is 20% or more. The adhesive is an acrylic or silicone-based adhesive.

A dialysate filter cartridge may be configured such that dialysate may be formed by passing saline solution through the dialysate filter cartridge. Once primed with saline, the dialysate cartridge may produce dialysate through recirculation through the cartridge. The dialysate filter cartridge may be configured with a higher concentration of several dialysate components such that the saline or other base liquid may absorb the components from the dialysate filter to create dialysate. The newly-formed dialysate may recirculate in the dialysis system for a period of time to equilibrate. Once the dialysate has reached a target measurement, dialysis may begin. The saline or other base liquid may be a readily available and lower cost base liquid for dialysate, and may include saline solution, distilled water, or other base liquid. For each base liquid, a corresponding dialysate filter may be configured to produce dialysate with the target components.

This utility model discloses a feeding tube with a flushing function, relating to the field of enteral feeding tube technology. It includes a silicone tube with a pin connector and a pagoda connector fixedly connected to its top and bottom ends, respectively. From top to bottom, the silicone tube is equipped with a drip bottle, a speed controller, and a medication inlet. The medication inlet is Y-shaped, and the silicone tube connects to one port at the top and one port at the bottom of the medication inlet. A flushing mechanism is connected to the other port at the top of the medication inlet. This utility model connects a flushing tube to the medication inlet of the flushing tube, and the flushing tube contains a storage chamber and a piston. The piston pushes saline solution from the storage chamber into the feeding tube, achieving flushing of the inside of the feeding tube. Through the cooperation of a ball screw and a ball nut, the saline solution is flushed at a pulsed frequency, reducing irritation to the intestines during saline injection.

The disclosure refers to a composition comprising poly(3-hexylthiophene) nanoparticles suspended in a saline solution comprising a stabilizing agent selected from a non-ionic surfactant, a water-soluble polymer having high intrinsic viscosity and a combination thereof. The preferred water-soluble polymer is hyaluronic acid. The saline solution is an aqueous solution comprising at least sodium ions and chloride ions. The saline solution may further comprise at least one of: magnesium ions, calcium ions, potassium ions, and combination thereof. The formulation has demonstrated an improved effectiveness in restoring a visual response in the RCS rat model of blindness and is potentially effective in the treatment of human retinal dystrophies such as retinitis pigmentosa (RP) and macular degeneration (AMD).

Provided is animal litter, wherein granular matters can adequately absorb urine, and wherein the granular matters can form small clumps having high strength at an early stage. Animal litter includes granular matters mainly composed of bentonite. The granular matters include 80% by mass or more of the granular matters having a grain size of 0.5 mm or more and 1.5 or less. Clump strength of a clump of the granular matters after 1 minute has elapsed since addition of 20 ml of a 0.9% by mass saline solution to the animal litter is 8.0 N or more.

The utility model relates to the technical field of foot bath barrels, and discloses a foot bath barrel with a disinfection function, which comprises a barrel body, the top of the barrel body is fixedly connected with an adjusting component for controlling water temperature, the inside of the barrel body is fixedly connected with a sealing plate, the top of the sealing plate is fixedly connected with a drainage component for draining water, and the top of the sealing plate is fixedly connected with a water storage tank. A mounting block is fixedly connected to the left side of the barrel body, a top cover is rotatably connected to the top of the mounting block, a connecting cylinder is fixedly connected to the interior of the top cover, a threaded cover is in threaded connection to the top of the connecting cylinder, two electrolytic cells are formed in the mounting block, an anode is fixedly connected to the interior of one electrolytic cell, and a cathode is fixedly connected to the interior of the other electrolytic cell. And a cathode is fixedly connected to the inside of the other electrolytic cell. According to the utility model, the acidic electrolyzed oxidizing water and the alkaline electrolyzed water are generated by electrolyzing the saline solution, so that the feet, the legs and the foot bath barrel are comprehensively disinfected. Various bacteria and viruses can be effectively killed, and the infection risk is reduced.